Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00289796
Status:
COMPLETED
Last Update Posted:
2017-02-08
First Post:
2006-02-09
Brief Title:
Assess Feasibility of an Acellular Pertussis Vaccine Pa Given Soon After Birth Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPVHib Vaccine
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2006-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-09
First Submit QC Date:
February 9 2006
Study First Post Date:
2006-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-06
Last Update Post Date:
2017-02-08
Last Update Post Date Type:
ESTIMATED